Dld Asset Management, LP Biogen Inc. Call Options Transaction History

Dld Asset Management, LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $5.69 Million - $7.42 Million	-20,100 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $518,000 - $829,420	2,000 Added 11.05%	20,100 $6.97 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $8.28 Million - $9.71 Million	-34,100 Reduced 65.33%	18,100 $5.07 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $12.3 Million - $18.6 Million	52,200 New	52,200 $12.8 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $66.8 Million - $92.3 Million	-303,400 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $66 Million - $74 Million	303,400 New	303,400 $70.7 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.